Rationale and design of the leipzig (LIFE) heart study: Phenotyping and cardiovascular characteristics of patients with coronary artery disease

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Beutner, Frank ^a,b   Teupser, Daniel ^a,b   Gielen, Stephan ^b   Holdt, Lesca Miriam ^a,b   Scholz, Markus ^b   Boudriot, Enno ^b   Schuler, Gerhard ^b   Thiery, Joachim ^a,b  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CHROMOSOME 9P; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DATA BASE; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PHENOTYPE; STUDY DESIGN; ADOLESCENT; AGED; CHROMOSOME 9; CLINICAL TRIAL; GENETIC PREDISPOSITION; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR;

ADOLESCENT; AGED; CHROMOSOMES, HUMAN, PAIR 9; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; PHENOTYPE; RESEARCH DESIGN; RISK FACTORS;

EID: 84055216956     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029070     Document Type: Article

References (25)

1. Mathers CD, Loncar D, (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3 (11): e442.
2. Gerszten RE, Wang TJ, (2008) The search for new cardiovascular biomarkers. Nature 451 (7181): 949-52.
3. Luo AK, Jefferson BK, Garcia MJ, Ginsburg GS, Topol EJ, (2007) Challenges in the phenotypic characterisation of patients in genetic studies of coronary artery disease. J Med Genet 44 (3): 161-5.
4. Damani SB, Topol EJ, (2007) Future use of genomics in coronary artery disease. J Am Coll Cardiol 50 (20): 1933-40.
5. Alvarez-Llamas G, de la Cuesta F, Barderas ME, Darde V, Padial LR, et al. (2008) Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective. Expert Rev Proteomics 5 (5): 679-91.
6. Edwards AV, White MY, Cordwell SJ, (2008) The role of proteomics in clinical cardiovascular biomarker discovery. Mol Cell Proteomics 7 (10): 1824-37.
7. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, et al. (2007) A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316 (5830): 1491-3.
8. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, et al. (2007) A common allele on chromosome 9 associated with coronary heart disease. Science 316 (5830): 1488-91.
9. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, et al. (2007) WTCCC and the Cardiogenics Consortium (2007). Genomewide association analysis of coronary artery disease. N Engl J Med 357 (5): 443-53.
10. Abdullah KG, Li L, Shen GQ, Hu Y, Yang Y, et al. (2008) Four SNPS on Chromosome 9p21 Confer Risk to Premature, Familial CAD and MI in an American Caucasian Population (GeneQuest). Ann Hum Genet 72 (5): 654-657.
11. Baker M, (2008) Genetics by numbers. Nature 451 (31): 516-518.
12. Patel M, Peterson E, Dai D, Brennan JM, Redberg RF, et al. (2010) Low diagnostic yield of elective coronary angiography. N Engl J Med 362: 886-95.
13. Schunkert H, Götz A, Braund P, McGinnis R, Tregouet DA, et al. (2008) Cardiogenics Consortium (2008). Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation 117 (13): 1675-1684.
14. Kitsios GD, Dahabreh IJ, Trikalinos TA, Schmid CH, Huggins GS, et al. (2011) Heterogeneity of the phenotypic definition of coronary artery disease and its impact on genetic association studies. Circ Cardiovasc Genet 4: 58-67.
15. Agah R, Ellis S, Chase S, Henderson M, Mlady L, et al. (2005) Creation of a large-scale genetic data bank for cardiovascular association studies. Am Heart J 150 (3): 500-6.
16. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, et al. (2002) Multi-ethic study of atherosclerosis: objective and design. Am J Epidemiol 156: 871-881.
17. Schmermund A, Möhlenkamp S, Stang A, Grönemeyer D, Seibel R, et al. (2002) Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study, Risk Factors, Evaluation of Coronary Calcium and Lifetsyle. Am Heart J 144 (2): 212-8.
18. Munterdam P, McCall C, Sanz J, Falk E, Fuster V, High-Risk Plaque Initiative (2010) The BioImage Study: novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovasular disease- study design and objectives. Am Heart J 2010; 160 (1): 52-7.
19. Holdt LM, Beutner F, Scholz M, Gielen S, Gäbel G, et al. (2010) ANRIL expression is associated with atherosclerotic risk at chromosome 9p21. Arterioscler Thromb Vasc Biol 30 (3): 620-7.
20. Wellcome Trust Case Control Consortium (2007) Genome-wide study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (7145): 661-78.
21. Palomaki GE, Melillo S, Bradley L, (2010) Association between 9p21 genomic markers and heart disease. JAMA 303 (7): 648-56.
22. Teupser D, Baber R, Ceglarek U, Scholz M, Illig T, et al. (2010) Genetic regulation of serum phytosterol levels and risk of coronary artery disease. Circ Cardiovasc Genet 3 (4): 331-9.
23. Fischer M, Broeckel U, Holmer S, Baessler A, Hengstenberg C, et al. (2005) Distinct heritable patterns of angiographic coronary artery disease in families with myocardial infarction. Circulation 111 (7): 855-62.
24. Fischer M, Mayer B, Baessler A, Riegger G, Erdmann J, et al. (2007) Familial aggregation of left main coronary artery disease and future risk of coronary events in asymptomatic siblings of affected patients. Eur Heart J 28 (20): 2432-7.
25. Dandona S, Stewart AF, Chen L, Williams K, So D, et al. (2010) Gene dosage of the common variant 9p21 predicts severity of coronary artery disease. J Am Coll Cardiol 56 (6): 479-86.